MoneyTree™ Life Sciences Report: Q3 2016 update

PwC’s MoneyTree™ Life Sciences report brings you a quarterly publication based on US venture capital funding for the life sciences sector. Each issue contains the following sections: life sciences deals by quarter, stages, regional funding trends and a venture capital outlook. We also break down the life sciences sector into its subsegments, including biotech and medical device, to compare funding and investment trends by quarter.

Life sciences funding compared with total venture funding, 2014–2016

“Deal volume is a key performance indicator to measure investor confidence. However, even with volume down, the life sciences space continues to garner the most dollars behind the software industry.”

Greg Vlahos, Life Sciences Partner at PwC

Contact us

Greg Vlahos
Partner, US Pharmaceuticals & life sciences
Tel: +1 (408) 817 5029
Email

Follow us